Poolbeg Pharma PLC Announces Director/PDMR Shareholding

Director Share PurchaseLONDON, UK / ACCESSWIRE / February 22, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces that it has rece...

Related Keywords

London ,City Of ,United Kingdom ,Amryt Pharma ,Poolbeg Pharma ,Ian Oconnell ,Niall Gilchrist ,Anthony Farrell ,Phil Davies ,Charlie Beeson ,Geoff Nash ,Helena Bates ,Nigel Birks ,Nick Bastin ,Jeremy Skillington ,Linkedin Poolbegpharma ,Sam Butcher ,Strategic Communications ,London Stock Exchange ,Twitter ,Financial Conduct Authority ,Poolbeg Pharma Plc ,Regulatory Information Service ,Director Share ,Chief Executive Officer ,Market Abuse Regulations ,Capital Markets Ltd ,Nominated Adviser ,Joint Broker ,Harriet Ward ,Capital Markets ,Vici Rabbetts ,Stock Exchange ,London Stock ,Primary Information Provider ,